Suppr超能文献

甲状腺疾病、非甲状腺疾病及对照中的抗甲状腺过氧化物酶(抗-TPO)抗体。一种检测抗-TPO(甲状腺微粒体)自身抗体的新型商业方法的临床有效性。

Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies.

作者信息

Engler H, Riesen W F, Keller B

机构信息

Institute of Clinical Chemistry and Haematology, St. Gallen, Switzerland.

出版信息

Clin Chim Acta. 1994 Mar;225(2):123-36. doi: 10.1016/0009-8981(94)90040-x.

Abstract

The identification of the thyroid peroxidase (TPO) as the main antigen of the thyroid microsomal fraction has enabled the development of a sensitive and specific assay for detection of the corresponding autoantibodies. We evaluated the diagnostic validity of the anti-TPO assay in 303 patients with different types of thyroid disease and in controls. Clearly elevated anti-TPO values (anti-TPO > 500 units/ml) were found in 59% of patients with thyroiditis but in none of the controls or the patients with non-thyroidal illness. The mean anti-TPO levels in these two control groups were 26 +/- 31 units/ml (mean +/- S.D.) and 39 +/- 34 units/ml, respectively. The highest frequency of positive results (88%) was obtained in patients with auto-immune hypothyroidism (clinical diagnosis: Hashimoto's thyroiditis) followed by patients with Graves' disease (53%). With a cut-off point of 200 units/ml, a sensitivity of 96% was obtained for Hashimoto's thyroiditis and of 59% for Graves' disease with a specificity of 100% (50 cases). The new method (anti-TPO, Dynotest) was compared with three conventional methods (35 samples). The results for all measurements were in general agreement. In two cases the results were clearly discordant: one sample contained high anti-thyroglobulin antibody concentrations, the other was obtained from a patient with non-thyroidal illness. In both instances the 'classical' assays yielded false-positive results. Treatment of autoimmune hyperthyroidism resulted in a median decrease in anti-TPO levels of over 50% after reaching the euthyroid state (P < 0.05), whereas in persistent hyperthyroidism no consistent changes were observed. In autoimmune hypothyroidism a marked variability in anti-TPO levels was noted. Some patients showed a clear decrease in anti-TPO levels during T4 substitution whereas in others no consistent changes were observed.

摘要

甲状腺过氧化物酶(TPO)被鉴定为甲状腺微粒体部分的主要抗原,这使得能够开发出一种灵敏且特异的检测相应自身抗体的检测方法。我们评估了抗TPO检测方法在303例不同类型甲状腺疾病患者及对照组中的诊断有效性。在59%的甲状腺炎患者中发现抗TPO值明显升高(抗TPO>500单位/毫升),但在对照组或非甲状腺疾病患者中均未发现。这两个对照组的平均抗TPO水平分别为26±31单位/毫升(平均值±标准差)和39±34单位/毫升。自身免疫性甲状腺功能减退症患者(临床诊断:桥本甲状腺炎)的阳性结果频率最高(88%),其次是格雷夫斯病患者(53%)。以200单位/毫升为临界值,桥本甲状腺炎的敏感性为96%,格雷夫斯病的敏感性为59%,特异性为100%(50例)。将新方法(抗TPO,Dynotest)与三种传统方法(35个样本)进行了比较。所有测量结果总体一致。在两例中结果明显不一致:一个样本中抗甲状腺球蛋白抗体浓度很高,另一个样本来自非甲状腺疾病患者。在这两种情况下,“经典”检测方法均产生了假阳性结果。自身免疫性甲状腺功能亢进症患者经治疗达到甲状腺功能正常状态后,抗TPO水平中位数下降超过50%(P<0.05),而持续性甲状腺功能亢进症患者未观察到一致变化。在自身免疫性甲状腺功能减退症患者中,抗TPO水平存在明显差异。一些患者在进行T4替代治疗期间抗TPO水平明显下降,而另一些患者未观察到一致变化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验